International Medical Director - Clinical Development, Haematology

at  Novo Nordisk

International Medical Director - Clinical Development, Haematology
Category: Clinical Development
Location:Søborg, Capital Region of Denmark, DK
Are you passionate about finding new solutions for rare Hemato-renal diseases? Do you possess extensive experience in clinical development and a deep understanding of how immunology impacts these conditions? If so, we are looking for an International Medical Director (IMD) - Haematologist with longstanding Immunology experience like you. Your leadership will be crucial in guiding programs through every phase of study, from ideation to comprehensive analysis, transforming patient care and advancing the field of medicine. Join us at the forefront of medical innovation and make a difference in the lives of millions of patients.

QUALIFICATIONS:

To be considered for this position, we expect you to have the following qualifications:

• MD with 10 +years of experience in clinical development
• Skills in translational medicine, and early drug development, and Phase 1- 4 clinical development programs.
• Adept in clinical trial design, data analysis, and interpretation.
• Well-versed in regulatory and guideline compliance.
• 
  
• 5 years clinical experience as haematologist preferably with extensive immunology experience and rare renal disease understanding

• Embodiment of the department’s commitment to individual growth, team spirit, knowledge sharing, and fostering a diverse culture.
• Upholding the principles of open communication, collaboration, and continuous improvement, building trust and transparency with partners.

• Leading with strategic foresight and provide clinical leadership for all clinical deliverables within the assigned projects.
• Conducting BD assessments
• Designing and developing protocols for clinical trials, ensuring they meet regulatory and scientific standards, and focus on medically sound regulatory interactions, robust data analysis, and communication.
• Identifying and navigating potential challenges, risks, and roadblocks, creating solutions that align with global clinical development strategies.
• Fostering collaboration across networks to develop innovative clinical strategies for new treatments and spearhead the expansion of our scientific network